Cargando…
Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel
Rapid technological advances in molecular biology, including next-generation sequencing, have identified key genetic alterations in central nervous system (CNS) tumors. Accordingly, the fifth edition of the World Health Organization (WHO) CNS tumor classification was published in 2021. We analyzed 3...
Autores principales: | HIGA, Nayuta, AKAHANE, Toshiaki, YOKOYAMA, Seiya, YONEZAWA, Hajime, UCHIDA, Hiroyuki, FUJIO, Shingo, KIRISHIMA, Mari, TAKIGAWA, Kosuke, HATA, Nobuhiro, TOH, Keita, YAMAMOTO, Junkoh, HANAYA, Ryosuke, TANIMOTO, Akihide, YOSHIMOTO, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534570/ https://www.ncbi.nlm.nih.gov/pubmed/36031351 http://dx.doi.org/10.2176/jns-nmc.2022-0103 |
Ejemplares similares
-
MPC-18 CATEGORIZATION OF LOWER GRADE GLIOMA USING ONCOPANEL
por: Uchida, Hiroyuki, et al.
Publicado: (2019) -
MPC-15 FEASIBILITY OF GLIOMA SPECIFIC ONCOPANEL IN THE DIAGNOSIS OF GLIOMA
por: Yoshimoto, Koji, et al.
Publicado: (2019) -
Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022) -
Distribution and favorable prognostic implication of genomic
EGFR
alterations in
IDH
‐wildtype glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2022) -
Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma
por: Higa, Nayuta, et al.
Publicado: (2023)